Approximately 2.5 million people living with spinal cord injury (SCI) in the world. In Europe, at least 330 0001 individuals are paralyzed following an LME, and about 11,000 new cases are diagnosed each year. In addition to the social and human consequences désastreuses2, a recommendation of the Council of Europe (REC 1560 (2002)) 3 emphasizes the huge economic cost induit4 and concludes that “member states of the Council of Europe should make greater concerted efforts to support and fund research in this area. ”
Since its inception in March 2006, the European Federation of Spinal Cord Injury (European Federation Spinal Cord Injury – ESCIF) is committed to supporting and encouraging research on the LME. She has actively participated in the implementation of projects to gather information with its members and has worked with professionals and researchers specializing in LME European research efforts. The statutes of the ESCIF put forward the support of the federation for research that can improve the quality of life of people living with SCI but did not mention the research on functional recovery. In 2006, Europe, the possibility of a “treatment” against paralysis appeared to be a rather distant project.
Since then, however, neuroscience has made significant progress toward the treatment of paralysis, to the extent that functional recovery is now a realistic goal to some degree. Many promising research is currently in clinical trials worldwide, and still others are in preparation to pass the tests on humans. To promote these scientific advances and their application in humans, it is essential that there is support, funding and considerable infrastructure.
We, the ESCIF, representing hundreds of thousands of people living with SCI throughout Europe, strongly support research for regenerative spinal cord to help treat paralysis for those millions of people already infected and future.
Therefore, we urge member states of the Council of Europe, the European Union and the Member States of the European Union to support and invest in research for regenerative lesions of the spinal cord:
Increasing funding for basic research, translational and clinical research on regenerative lesions of the spinal cord;
Allowing a transfer within a period of promising research laboratories to patients with sufficient funding, efficient infrastructure and collaborative networks;
Adopting regulations and legislation adapted for efficient translation in a timely and promising research without compromising patient safety and ethics
Drawing up and implementing a Plan of Treatment of Spinal Cord Injury, for the treatment against the spinal cord a national and international priority.
Finally, it should be noted that research in the field of regenerative spinal cord also contribute to the search for other neurological diseases such as Multiple sclerosis, amyotrophic lateral sclerosis, Parkinson’s and Alzheimer’s disease..